CombiMatrix

Type: Company
Name: CombiMatrix
First reported Apr 16 2014 - Updated Apr 17 2014 - 1 reports

Molecular Diagnostics Markets

-- /PRNewswire/ --Research and Markets ( http://www.researchandmarkets.com/research/db83hw/molecular ) has announced the addition of the " " report to their offering.(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )The technologies that constitute ... [Published Sacramento Bee - Apr 16 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 3 reports

CombiMatrix names Sahoo head of cytogenetics

CombiMatrix (NASDAQ:CBMX) has named Dr. Trilochan Sahoo as director of cytogenetics, reporting to CMO Dr. Wes Tyson. Dr. Sahoo was previously senior director, clinical cytogenetics, with Quest Diagnostics Nichols Institute in San Juan Capistrano, California. ... [Published BioPortfolio - Apr 09 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

CombiMatrix Warrants: As Close To A Sure Zero As You Can Get

SummaryCBMXW is a microcap warrant misunderstood by many of its holders. It sells for over $2/warrant. It will almost certainly expire worthless in under 6 weeks. This is an astonishingly compelling short if you can find borrow.This is a very, very ... [Published Seeking Alpha - Mar 26 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

COMBIMATRIX CORP - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ ... [Published HispanicBusiness.com - Mar 24 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 2 reports

Technical Pointers - Top Gainers: Celldex Therapeutics, Sonus Networks, YOU On Demand Holdings, and CombiMatrix

SOURCE Investor-EdgeEditor Note: For more information about this release, please scroll to bottomLONDONOn Monday, March 17, 2014http://investor-edge.com/registerCelldex Therapeutics Inc.'s stock finished Monday's session at $24.18http://www.Investor-Edge.com/03182014/CLDX/report.pdf ... [Published WMDT ABC-47 - Mar 18 2014]
First reported Mar 17 2014 - Updated Mar 17 2014 - 3 reports

CombiMatrix Poised to Double -- or More

If your browser does not automatically forward you to http://business-news.thestreet.com/philly/story/combimatrix-poised-to-double-or-more/12532385, please click here. ... [Published Philly.com - Mar 17 2014]
Entities: CombiMatrix
First reported Mar 13 2014 - Updated Mar 13 2014 - 1 reports

Healthcare Review: Chelsea Therapeutics, CombiMatrix, Dara Biosciences, Merck, Galena

A downturn in U.S. stocks deepened Thursday afternoon as rhetoric between the U.S. and Russia over the conflict in Ukraine intensified.The decline put the Dow Jones industrial average on the path for its fourth loss in a row. The Standard & Poor's 500 ... [Published BioMedReports - Mar 13 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 5 reports

CombiMatrix to provide tests for American Pathology Partners

CombiMatrix ( CBMX ) will provide its tests for analyzing miscarriages to American Pathology Partners (AP2), which is creating a nationwide network of anatomic pathology laboratories. The partnership for the chromosomal microarray analysis (CMA) tests ... [Published Seeking Alpha - Mar 13 2014]
First reported Mar 10 2014 - Updated Mar 10 2014 - 4 reports

CombiMatrix names Weslie Tyson, M.D., as Chief Medical Officer

CombiMatrix announced that pediatric pathologist R. Weslie Tyson, M.D., has been hired as Chief Medical Officer, effective April 8. Dr. Tyson will replace Richard D. Hockett, Jr., M.D., as Chief Medical Officer, whose resignation was disclosed in a Form ... [Published Yahoo! Finance - Mar 10 2014]
First reported Feb 12 2014 - Updated Feb 12 2014 - 1 reports

CombiMatrix Reiterates Previously Reported Terms of Nasdaq Listed Warrants (Symbol: CBMXW)

About CombiMatrix Corporation CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support for the highest quality of care – specializing in miscarriage analysis, prenatal and pediatric healthcare. CombiMatrix ... [Published Stockwatch - Feb 12 2014]
First reported Jan 23 2014 - Updated Jan 23 2014 - 1 reports

CombiMatrix Announces Contract With Galaxy Health Network

Mark McDonough, President and Chief Executive Officer of CombiMatrix, noted that the partnership with Galaxy is another opportunity for CombiMatrix to broaden its payor geographic reach. "This agreement further expands our reach throughout the country ... [Published Stockwatch - Jan 23 2014]
First reported Jan 17 2014 - Updated Jan 17 2014 - 1 reports

CombiMatrix to Participate in the RedChip Emerging Growth Showcase

About CombiMatrix Corporation CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support for the highest quality of care – specializing in miscarriage analysis, prenatal and pediatric healthcare. CombiMatrix ... [Published Stockwatch - Jan 17 2014]

Quotes

...suppressor cells and providing increased tumor-specific immunity," said Jeff T Hutchins, Ph D , vice president of preclinical research at Peregrine. "These data also show that when combined with downstream immune checkpoint inhibitors such as anti-CTLA-4 and anti-PD-1, PS targeting mediates an improved protective tumor-specific immunity following tumor rechallenge. While these new downstream checkpoint inhibitors have been shown to strengthen the tumor-killing activity of T-cells and thus extend survival in some patients, there remains a need to increase the number of responders that mount anti-tumor T-cell responses in order to maximize the effects of these downstream checkpoint inhibitors. We believe a PS-targeting antibody, such as bavituximab, plays a key role in reducing tumor suppression and driving a more inclusive immune-mediated response. Insights from these data will influence our future clinical development plans including the soon to be opened investigator-sponsored trial assessing the potential of bavituximab and an anti-CTLA-4 antibody in patients with advanced melanoma."
...with the high caliber of physician talent that we have added to the CombiMatrix team in the past few weeks," President and CEO Mark McDonough said. "Dr. Tyson and Dr. Sahoo are well-published individuals who bring outstanding expertise in developmental disorders and prenatal pathology to our already strong medical team. Now that we have built out our medical organization, we will continue to hire sales talent in the second quarter of 2014 and complete our 'post funding' expansion from 6 to 15 field sales representatives by end of June 2014, in order to capitalize on the outstanding opportunity in microarray-based prenatal diagnostics that is in front of us."
...Her current product lines include medical supplies and high technology to Moscow distributors. Commented Dr. Rubin, "I mentioned that I practice Oral and Maxillofacial Surgery and that I recently expanded my services with Photonic light and Laser therapy enhanced with the use of Chinese herbs and Rain Forest botanicals."
...CMA testing for miscarriage analysis -- also called Product of Conception (POC) testing -- is a natural extension of AP2's product offerings. "Our goal is to provide the best patient care possible and to that end we are very pleased to be working with an advanced laboratory like CombiMatrix that specializes in CMA testing and has become a leader in the POC testing market. We believe this partnership will prove to be beneficial for both AP2's referring clinicians and their patients."

More Content

All (60) | News (43) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (17)
sort by: Date | Relevance
Molecular Diagnostics Markets [Published Sacramento Bee - Apr 16 2014]
Peregrine Reports Data on Bavituximab; Keryx Re... [Published BioMedReports - Apr 10 2014]
CombiMatrix names Sahoo head of cytogenetics [Published BioPortfolio - Apr 09 2014]
CombiMatrix Names Trilochan Sahoo, M.D., Direct... [Published Virtual Strategy Magazine - Apr 09 2014]
CombiMatrix Names Trilochan Sahoo, M.D., Direct... [Published GlobeNewswire: Acquisitions News - Apr 09 2014]
CombiMatrix Names Trilochan Sahoo, M.D., Direct... [Published Benzinga.com - Apr 09 2014]
CombiMatrix Warrants: As Close To A Sure Zero A... [Published Seeking Alpha - Mar 26 2014]
COMBIMATRIX CORP - 10-K - MANAGEMENT'S DISCUSSI... [Published HispanicBusiness.com - Mar 24 2014]
Technical Pointers - Top Gainers: Celldex Thera... [Published MSN Money - Mar 18 2014]
Technical Pointers - Top Gainers: Celldex Thera... [Published WMDT ABC-47 - Mar 18 2014]
Technical Pointers - Top Gainers: Celldex Thera... [Published PR Newswire - Mar 18 2014]
CombiMatrix Poised to Double -- or More [Published Philly.com - Mar 17 2014]
CombiMatrix Poised to Double -- or More [Published Daily Freeman - Mar 17 2014]
CombiMatrix Poised to Double -- or More [Published The Street Latest - Mar 17 2014]
SADIF Analytics releases new summary due dilige... [Published PR inside - Mar 17 2014]
FDA Approves First ICD to be Evaluated in US Cl... [Published BioMedReports - Mar 14 2014]
Photo Advisory: Glenn Close and Family Received... [Published BioMedReports - Mar 13 2014]
Healthcare Review: Chelsea Therapeutics, CombiM... [Published BioMedReports - Mar 13 2014]
CombiMatrix to provide tests for American Patho... [Published Seeking Alpha - Mar 13 2014]
CombiMatrix Announces Partnership With American... [Published Noodls - Mar 13 2014]
CombiMatrix Announces Partnership With American... [Published GlobeNewswire: Acquisitions News - Mar 13 2014]
CombiMatrix Announces Partnership With American... [Published Nasdaq - Mar 13 2014]
CombiMatrix Announces Partnership With American... [Published BioMedReports - Mar 13 2014]
CombiMatrix Announces Partnership With American... [Published Benzinga.com - Mar 13 2014]
Wright Medical Group Announces Deal with FDA Of... [Published BioMedReports - Mar 11 2014]
Mission San Juan Capistrano will host Return of... [Published Huntington Beach News - Mar 10 2014]
CombiMatrix names Weslie Tyson, M.D., as Chief ... [Published Yahoo! Finance - Mar 10 2014]
CombiMatrix Hires R. Weslie Tyson, M.D., as Chi... [Published SPi World News - Mar 10 2014]
CombiMatrix Hires R. Weslie Tyson, M.D., as Chi... [Published GlobeNewswire: Advertising News - Mar 10 2014]
CombiMatrix Hires R. Weslie Tyson, M.D., as Chi... [Published Nasdaq - Mar 10 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
CombiMatrix Names Trilochan Sahoo, M.D., Direct... [Published GlobeNewswire: Acquisitions News - Apr 09 2014]
CombiMatrix Announces Partnership With American... [Published GlobeNewswire: Acquisitions News - Mar 13 2014]
CombiMatrix Hires R. Weslie Tyson, M.D., as Chi... [Published GlobeNewswire: Advertising News - Mar 10 2014]
CombiMatrix to Present at the 26th Annual ROTH ... [Published GlobeNewswire: Acquisitions News - Mar 04 2014]
CombiMatrix Corporation Reports Results for 201... [Published GlobeNewswire: Advertising News - Feb 19 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.